New Medtek Devices ( USA ) Limited
New Medtek Devices ( USA ) Limited is a medical device company specializing in postoperative pain management solutions for hemorrhoidectomy patients. The company aims to reduce opioid reliance by developing wearable systems for targeted, programmable local anesthetic delivery. Its flagship device is ARTG-listed and designed to improve patient recovery and outcomes.
New Medtek Devices ( USA ) Limited
Suite 103, 50 Berry Street, North Sydney, NSW 2060, Australia
New Medtek Devices ( USA ) Limited is currently seeking investment
New Medtek Devices ( USA ) Limited is seeking a series-a investment in the range of 1m-5m
Patents
What We Do
A wearable, programmable device enabling continuous or patient-controlled infusion of local anaesthetic to nerve sites after haemorrhoidectomy surgery. Designed to reduce postoperative pain and opioid use.
Provision of resources, training, and support materials to healthcare professionals adopting targeted infusion pain management devices.
Battlefield Resuscitation
Key People
Ed Hutcherson
Sales Manager
Val Theisz
Head of Quality and Strategy
James Bencke
Head of Product and Operations
Edwina Lim
Medtech Commercialisation Consultant
Gary Zamel
Chairman /President
Professor David Lubowski AM
Chief Medical Officer
Leslie Butterfield
Non-Executive Director
Dr Bronwyn Evans
Board Member
Professor Graham Newstead
Advisory Committee Member
Professor Peter Farrell
Advisory Committee Member
Dr. Joshua Gunn
Chief Scientist, Advisory Committee Member
Greg Plamondon
CEO
News & Updates
Wearable pain management surgical kit included in the Australian Register of Therapeutic Goods (ARTG No. 511628).
Announcement of regulatory approval as a Class IIb Medical Device for post-haemorrhoidectomy pain management.
